BusinessDS Healthcare's internal investigation on management and former DirectorsBy Nasdaq OMXApr 2, 2016, 10:45 PM UTC
BusinessSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DS Healthcare Group, Inc.By Nasdaq OMXMar 30, 2016, 3:51 PM UTC
BusinessRodman & Renshaw Reiterates Buy Rating With a $6.00 Price Target for DS Healthcare Group, Inc.By Nasdaq OMXMar 2, 2016, 3:33 PM UTC
BusinessDS Healthcare Announces Transformative Acquisition of Medical Device and Dermatology BusinessesBy Nasdaq OMXFeb 22, 2016, 2:30 PM UTC
